# Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis

> **NCT02982083** · NA · COMPLETED · sponsor: **Sara Saeidi Shahri** · enrollment: 34 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Raloxifene hydrochloride
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT02982083
- **Lead sponsor:** Sara Saeidi Shahri
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2019-12
- **Final completion:** 2020-09
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2021-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02982083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02982083, "Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02982083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*